Associate Professor of Radiation and Cellular Oncology, University of Chicago Medicine
Radiation Oncology
Dr. Steven J. Chmura, MD
|
|
Give Review
Steven Chmura practices Radiation Oncology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Steven J. Chmura is also published. He has 60 publications published. The lastest publication: "Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential.' Doctor Steven J. Chmura, MD is registered with Medicare and accepts Medicare payments.
Publications
- Taking "the Game" Out of The Match: A Simple Proposal.
- The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
- A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.
- Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.
- Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
- An Image-Guided Study of Setup Reproducibility of Postmastectomy Breast Cancer Patients Treated With Inverse-Planned Intensity Modulated Radiation Therapy.
- An analysis of radiation necrosis of the central nervous system treated with bevacizumab.
- A national radiation oncology medical student clerkship survey: didactic curricular components increase confidence in clinical competency.
- Radiation Oncology Medical Student Clerkship: Implementation and Evaluation of a Bi-institutional Pilot Curriculum.
- Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell-Mediated Killing.
- A Prospective Study of the Utility of Magnetic Resonance Imaging in Determining Candidacy for Partial Breast Irradiation.
- Radiation oncology fourth-year medical student clerkships: a targeted needs assessment.
- Hypofractionated Radiotherapy Does Not Increase Acute Toxicity in Large-Breasted Women: Results From a Prospectively Collected Series.
- The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.
- Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.
- Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
- Feasibility and Acute Toxicity of Hypofractionated Radiation in Large-breasted Patients.
- Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.
- Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
- Reirradiation of recurrent head and neck cancers with curative intent.
- Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
- Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.
- Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
- Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
- Is postmastectomy radiotherapy useful in elderly women with high-risk breast cancer?
- Evolving use of radiotherapy and radiosurgery in the treatment of pituitary adenomas.
- Optimization of the temporal pattern of radiation: an IMRT based study.
- Enhancing radiotherapy with genetically engineered viruses.
- Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
- Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulat...
- An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
- Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
- Characterization of a novel phantom for three-dimensional in vitro cell experiments.
- A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemoth...
- Validation of temporal optimization effects for a single fraction of radiation in vitro.
- AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging.
- Outcomes in black patients with early breast cancer treated with breast conservation therapy.
- Rationally simplified bistramide analog reversibly targets actin polymerization and inhibits cancer progression in vitro and in vivo.
- A novel functional CT contrast agent for molecular imaging of cancer.
- Predictors of competing mortality in early breast cancer.
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
- MicroRNA Expression Characterizes Oligometastasis(es).
- Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer.
- Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
- Calculation and prediction of the effect of respiratory motion on whole breast radiation therapy dose distributions.
- gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.
- Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.
- Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase.
- Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231.
- Loss of ceramide production confers resistance to radiation-induced apoptosis.
- Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.
- Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors.
- Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential.
- In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.
- Strategies for enhancing viral-based gene therapy using ionizing radiation.
- In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
- Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis.
- Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.
- Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Louis a Weiss Mem Hospital
University Of Chicago Hosps
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
University of Chicago Medical Center -
University of Illinois Hospital & Health Sciences System -
Jesse Brown Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1629137161 | |
| NPPES Provider LastName | CHMURA | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 605276686 | |
| NPPES Provider State | IL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629137161 |
| Last Name Of The Provider | CHMURA |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Daniel J. Haraf, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Azhar M. Awan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel Hellman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard J. Halpern, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Harold G. Sutton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip P. Connell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander C. Perez, MD
This Doctor is OpenDoctor Recommended.
|